Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C84005-250 250 µg (2.68 mg/ml) $451 
Antibody

Polyclonal Sheep anti‑Human EPOR / EPO Receptor Antibody (Extracellular Domain, IHC, WB) LS‑C84005

Polyclonal Sheep anti‑Human EPOR / EPO Receptor Antibody (Extracellular Domain, IHC, WB) LS‑C84005

Antibody:
EPOR / EPO Receptor Sheep anti-Human Polyclonal (Extracellular Domain) Antibody
Application:
IHC, ICC, WB, IP, ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified
Price
Catalog Number
$451
LS-C84005-250
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
EPOR / EPO Receptor Sheep anti-Human Polyclonal (Extracellular Domain) Antibody
Application:
IHC, ICC, WB, IP, ELISA
Reactivity:
Human, Mouse
Format:
Unconjugated, Unmodified

Specifications

Description
EPO Receptor antibody LS-C84005 is an unconjugated sheep polyclonal antibody to EPO Receptor (EPOR) (Extracellular Domain) from human. It is reactive with human and mouse. Validated for ELISA, ICC, IHC, IP and WB. Cited in 1 publication.
Target
Human EPOR / EPO Receptor
Synonyms
EPOR | EPO Receptor | EPO-R | Erythropoietin receptor
Host
Sheep
Reactivity
Human, Mouse (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Unmodified
Immunogen
Partial cDNA of the extracellular domain of human EpoR expressed as a GST fusion protein in E. coli.
Epitope
Extracellular Domain
Specificity
Antibody titers and specificity were analyzed by ELISA assay using control samples by varying concentration of GST-EpoR and control anti-GST antibody. Affinity purified antibody was found to detect EpoR at concentrations of 50 ng/ml. Neutralization of ligand binding has been detected using erythroleukemia cell line TF-1 with 3000 Epo receptors/cell to block Iodine 125 labeled erythropoietin ligand binding. This antibody will recognize EpoR-GST at its migration of 49 kD on SDS-PAGE. High quality secondary anti-sheep reagents are essential for this assay.
Applications
  • IHC
  • ICC
  • Western blot
  • Immunoprecipitation
  • ELISA (10 µg/ml)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, No preservatives added
Storage
Store at -20°C. Aliquot to avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About EPOR / EPO Receptor
P19235 NM_000121 NP_000112.1

LSBio Ratings

EPOR / EPO Receptor Antibody (Extracellular Domain) for IHC, ICC, WB/Western, IP, ELISA LS-C84005 has an LSBio Rating of
Publications (4)

Publications (1)

Erythropoietin acts as an anti-inflammatory signal on murine mast cells. Wiedenmann T, Ehrhardt S, Cerny D, Hildebrand D, Klein S, Heeg K, Kubatzky KF. Molecular immunology. May;65:68-76.

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/19/2024